| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,341 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$3,497,656 |
|
|
|
Indirect Value
|
$9,778,394 |
|
|
| Total
Shares |
711,090 |
|
|
| Total
Value |
$13,276,050 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
14
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -48.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-14 |
4 |
AS |
$17.66 |
$355,460 |
D/D |
(20,128) |
187,341 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-13 |
4 |
AS |
$17.29 |
$46,960 |
D/D |
(2,716) |
207,469 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-08 |
4 |
OE |
$0.68 |
$34,000 |
D/D |
50,000 |
210,185 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
539,307 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
170,157 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-23 |
4 |
AS |
$23.17 |
$58,435 |
I/I |
(2,522) |
518,989 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-21 |
4 |
S |
$22.59 |
$55,978 |
I/I |
(2,478) |
521,511 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-14 |
4 |
AS |
$23.67 |
$65,613 |
I/I |
(2,772) |
518,989 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-10 |
4 |
S |
$24.18 |
$68,986 |
I/I |
(2,853) |
521,761 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-07-18 |
4 |
AS |
$30.01 |
$291,157 |
I/I |
(9,702) |
518,989 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-07-17 |
4 |
AS |
$29.60 |
$296,000 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-07-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-05-15 |
4 |
AS |
$28.55 |
$286,044 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-05-15 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-13 |
4 |
AS |
$25.04 |
$122,646 |
I/I |
(4,898) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-13 |
4 |
OE |
$5.28 |
$25,861 |
I/I |
4,898 |
533,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-12 |
4 |
OE |
$5.28 |
$26,939 |
I/I |
5,102 |
533,793 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-12 |
4 |
AS |
$25.04 |
$127,754 |
I/I |
(5,102) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-13 |
4 |
S |
$30.09 |
$105,225 |
I/I |
(3,497) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-13 |
4 |
OE |
$0.68 |
$17,000 |
I/I |
25,000 |
524,902 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-08 |
4 |
S |
$30.89 |
$46,984 |
I/I |
(1,521) |
499,902 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-17 |
4 |
AS |
$29.53 |
$295,339 |
I/I |
(10,000) |
497,173 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
507,173 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-05 |
4 |
S |
$28.44 |
$74,968 |
I/I |
(2,636) |
497,173 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-04 |
4/A |
S |
$28.70 |
$83,574 |
I/I |
(2,912) |
492,309 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
